Pause in NIH patents slows new treatment development
Clampdowns on external communications and new contracts at the National Institutes of Health by President Trump’s administration — which have effectively slowed the flow of grant funding to a trickle — are also blocking the agency from sharing research materials with collaborators and taking crucial steps to ensure the discoveries its own scientists are making